I
nsulin-like growth factor-1 (IGF-1) is a critical growth factor for various types of cells. Challenge of target cells with IGF-1 results in a pleiotropic response that can include cellular proliferation or differentiation, stimulation of amino acid uptake, glycogen metabolism, and induction of mRNA and protein synthesis. IGF-1 is also known to play important roles in cardiac hypertrophy and heart failure. Ito et al 1 demonstrated that IGF-1 caused cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured cardiomyocytes. Duerr et al 2 reported that IGF-1 enhanced ventricular hypertrophy and function in in vivo rat heart with experimental myocardial infarction. Ambler et al 3 reported that IGF-1 also improved cardiac dysfunction in doxorubicininduced cardiomyopathy. Many recent studies have shown that IGF-1 increased [Ca 2ϩ ] transient in cardiomyocytes, improved cardiac contractility, 4, 5 preserved ischemic myocardium from reperfusion injury, 6 and protected against cardiac necrosis and inhibition of reperfusion-induced apoptosis of cardiac myocytes. 7 Reiss et al 8 reported that IGF-1 and the IGF-1 receptor system were upregulated in experimental myocardial infarction. Recent clinical studies have demonstrated that growth hormone improved heart failure in patients with dilated cardiomyopathy. 9 IGF-1, previously known as somatomedin, increased with growth hormone treatment 10 and is considered to play a critical role in improving cardiac function. 2 These findings indicated that IGF-1 might be a critical growth factor for cardiomyocytes; however, its precise signal transduction pathways and their roles in cardiomyocytes remain unclear. 11, 12 The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathways are activated by various cytokines and growth factors such as interleukin-6 (IL-6), epidermal growth factor, and platelet-derived growth factor. 13 We and others have recently reported that cardiotrophin-1 and leukemia inhibitory factor (LIF) caused cardiac hypertrophy and activated the JAK/STAT pathway in cardiomyocytes. 14 -16 We also reported that the JAK/STAT pathway was activated by angiotensin II in cultured cardiomyocytes 17 and pressure-overloaded rat heart. 18 Recently, Kunisada et al 19 reported that overexpression of STAT3 using an adenovirus system augmented c-fos and atrial natriuretic factor (ANF) mRNA expression and protein synthesis in LIF-stimulated cardiomyocytes, whereas overexpression of dominantnegative STAT3 attenuated c-fos and ANF mRNA expression and protein synthesis. These results indicated that STAT3-dependent signaling might promote cardiomyocyte hypertrophy. Fujio et al 20 reported that LIF phosphorylated STAT1 and induced the antiapoptotic cytoprotective gene bcl-xL, and that the activation of STAT1, but not STAT3, could induce bcl-xL in cardiomyocytes. Taken together, the JAK/STAT pathway might be critically involved in mediating cardiac hypertrophy and presenting a cytoprotective effect in cardiomyocytes.
IGF-1 activates various signaling pathways including the IRS-1/PI-3K, ras/raf-1/extracellular responsive kinase (ERK), and PTP1D pathways. 21 However, it remains unclear whether IGF-1 can signal through the JAK/STAT pathway, especially in cardiomyocytes. Considering that IGF-1 has both hypertrophic and antiapoptotic effects on cardiomyocytes, and that other tyrosine kinase-binding receptors use this pathway, there is a possibility that IGF-1 signals through this pathway. In the present study, we report that IGF-1 induced characteristic activation of JAK1, STAT1, and STAT3 in rat cardiomyocytes and have assessed the upstream signals of serine and tyrosine phosphorylation of STAT1 and STAT3.
Materials and Methods

Materials
Recombinant IGF-1 was provided by Fujisawa Pharmaceuticals Co Ltd. Antibodies to JAK1, JAK2, Tyk2, STAT1␣/␤, STAT3, and ERK1/2, specific substrate for Raf-1 (PLARTLSVAGLPGKK), and the synthetic oligonucleotide probes for SIE and mutant SIE were purchased from Santa Cruz Biotechnology. The sequences of the probes have been described (SIE: 5Ј-GTGCATTTCCCG-TAAATCTTGTCTACA-3Ј, mutant SIE: 5Ј-GTGCATCCACCGT-AAATCTTGTCTACA-3Ј). Monoclonal antibody to phosphotyrosine (4G10) was purchased from Upstate Biotechnology. Polyclonal and monoclonal antibodies to phosphoserine were purchased from Zymed Laboratories and Sigma. Polyclonal antiphosphospecific mitogen-activated protein kinase (MAPK) antibody was purchased from New England Biolabs.
Cell Culture
Primary cultures of cardiomyocytes were prepared from the ventricles of 1-day-old Wistar rats as described previously (Japan CLEA, Tokyo, Japan). 14 The cells were incubated in serum-free medium for 24 hours and then stimulated with IGF-1 (10 Ϫ8 mol/L).
Immunoprecipitation (IP) and Western Blot Analysis
The cells were lysed in a buffer as described previously. 17 The lysates were precleared by incubation with protein A-Sepharose beads (Sigma). Precipitating antibodies were added to the lysates, and the lysates were incubated for 3 hours at 4°C. Immunoprecipitates were pelleted with protein A-Sepharose beads and washed 4 times with the lysis buffer. The precipitated proteins were subjected to SDS-PAGE, and Western blot analysis was performed as described. 17 Kinase Activity Assays for Raf-1 
Gel Mobility Shift Assay
Nuclear extracts were prepared according to standard methods as described previously. 22 Briefly, harvested cells were resuspended in 5 vol of hypotonic buffer, incubated for 10 minutes on ice, and centrifuged. The cells were then resuspended in 2 vol of the same buffer, Dounce-homogenized, and spun at 1000g for 10 minutes, and the pelleted nuclei were incubated for 30 minutes at 4°C in high salt buffer. The nuclear extracts were dialyzed against dialysis buffer overnight. The protein concentrations were determined by Bradford's method. Nuclear extracts (5 g) were incubated with 1 g of poly(dI-dC)-poly(dI-dC) in 20 L of 25 mmol/L HEPES (pH 7.9), 50 mmol/L KCl, 0.5 mmol/L EDTA, and 10% glycerol for 20 minutes at 25°C. The samples were incubated with 1 fmol/L of radiolabeled probes (Ϸ5000 cpm) for 10 minutes at 25°C. Binding reactions were resolved by 4% native polyacrylamide gel electrophoresis containing 1ϫ Tris-acetate/EDTA electrophoresis buffer and visualized by autoradiography.
Statistical Analysis
Values are presented as meanϮSD. Statistical significance among mean values was evaluated with ANOVA. Student's t test was used when two values were compared. Differences were considered to be significant at values of PϽ0.05.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results
IGF-1 Phosphorylates JAK1 but Not JAK2 or Tyk2 in Cardiomyocytes
To determine whether IGF-1 transduces signaling through the JAK/STAT pathway in cardiomyocytes, we performed IP Western blotting to detect the tyrosine phosphorylation of JAK family kinases. Four members have been identified so far: JAK-1, JAK-2, JAK-3, and Tyk-2. JAK-1, JAK-2, and Tyk-2 are ubiquitous, whereas JAK-3 is expressed only in T lymphocytes. LIF was used as a positive control. IGF-1 phosphorylated JAK1 as early as 2 minutes, peaked at 5 minutes, and decreased thereafter ( Figure 1A ). The time course of the phosphorylation of JAK1 was equivalent to that of LIF. In contrast, neither JAK2 nor Tyk2 was phosphorylated after IGF-1 treatment ( Figure 1B ), whereas LIF clearly led to phosphorylation of JAK2 and Tyk2. Similar results were obtained in 3 additional experiments. These findings indicated that JAK1, but not JAK2 or Tyk2, was involved in IGF-1 signaling.
IGF-1 Activates the Raf-1/MAPK/ERK Kinase (MEK)/ERK Pathway in Cardiomyocytes
IGF-1 activates Raf-1/MEK/ERK pathway in various types of cells. 23 A recent study suggested that this pathway plays an important role in the serine phosphorylation of STAT families. Thus, to confirm that IGF-1 activated this pathway in cardiomyocytes, we detected the MAPKKK activity of Raf-1 and the phosphorylation of ERK after IGF-1 stimulation. The MAPKKK activity of Raf-1 increased as early as 2 minutes, peaked at 5 minutes, and returned to the control level by 30 minutes (Figure 2A ). The serine phosphorylation of ERK1/2 was detected by Western blot analysis using antiphosphospe-
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cific MAPK antibodies. Phosphorylation of ERK1 and ERK2 increased at 2 minutes, peaked at 5 minutes, and decreased to the control level at 30 minutes ( Figure 2B ). These findings show that the Raf-1/MEK/ERK pathway was also involved in IGF-1-regulated signaling in cardiomyocytes.
Tyrosine Phosphorylation of STAT1 and STAT3 by IGF-1 in Cardiomyocytes
Next, we performed IP Western blot analysis to detect the tyrosine phosphorylation of STAT families. STAT1 and STAT3 were unphosphorylated in unstimulated cells. After IGF-1 stimulation, tyrosine phosphorylation of STAT1 was observed at 2 minutes and peaked at 15 minutes but could not be observed at 30 minutes ( Figure 3A ). Tyrosine phosphorylation of STAT1 by LIF was observed at 5 minutes, peaked at 15 minutes, and returned to the control level at 30 minutes. The time course of the phosphorylation of STAT1 by IGF-1 was almost similar to that by LIF.
In contrast, IGF-1-induced tyrosine phosphorylation of STAT3 showed a pattern quite distinctive from that of STAT1. In this unique time course, phosphorylation was observed as early as 2 minutes, gradually increased to peak at 60 minutes, and was still sustained at 120 minutes ( Figure   3B ). The results were reproducible in 5 separate experiments. Phosphorylation of STAT3 by LIF was observed at 2 minutes, was maximal at 5 minutes, and was not observed at 30 minutes. The time course of the phosphorylation of STAT3 by IGF-1 was quite different from that by LIF. The early phase of tyrosine phosphorylation of STAT3 by IGF-1 could be explained by JAK1, but it was difficult to explain that this slow time course of the phosphorylation of STAT3 was caused by JAK1 alone, suggesting that STAT3 was phosphorylated by another kinase. Next, we compared the strength of IGF-1-induced phosphorylation of STAT3 with that by LIF. We stimulated the cells with various doses of LIF for 5 minutes or IGF-1 for 60 minutes and quantitated tyrosine phosphorylation of STAT3 by densitometric analysis ( Figure  3C ). The maximal strength of phosphorylation of STAT3 by IGF-1 was 12Ϯ3% of that by LIF.
Serine Phosphorylation of STAT1 and STAT3 by IGF-1
Recent studies revealed that serine phosphorylation of STAT1 and STAT3 was important for maximal transcription. 24 phosphorylation of STAT3 by IGF-1 was also slow, as was the tyrosine phosphorylation.
Gel Mobility Shift of SIE
The results of the IP Western blot analysis of STATs indicated that STAT1 and STAT3 were differentially regulated in IGF-1 stimulation. Homodimers or heterodimers of STAT1 and STAT3 form sis-inducing factor (SIF) complexes and translocate into the nucleus. Therefore, a gel mobility shift assay was used to examine sis-inducing element (SIE) ( Figure 5 ). IGF-1 induced the formation of SIF complex associated with intranuclear oligonucleotides corresponding to SIE as early as 5 minutes. This DNA-protein interaction was maximal at 60 minutes. The time course of the shift of SIE bands corresponded to that of the tyrosine phosphorylation of STAT3.
Upstream Signals of the Tyrosine Phosphorylation of STAT3
The time course of the tyrosine phosphorylation of STAT3 was dissociated from the time course of the activation of JAK1. To show whether IGF-1 induced secretion of other growth factors such as angiotensin II, endothelin-1, or IL-6 family cytokines, which may in turn phosphorylate STAT3 in the late phase, we preincubated the cells with CV11974 (AT 1 antagonist: 10 Ϫ6 mol/L) or TAK044 (endothelin-1 type A and B receptor antagonist: 10 Ϫ6 mol/L) and observed the tyrosine phosphorylation of STAT3 at 60 minutes ( Figure 6A ). CV11974 and TAK044 did not affect the tyrosine phosphorylation of STAT3, suggesting that neither angiotensin II nor endothelin-1 was involved in this phosphorylation. To confirm whether paracrine-secreted IL-6 family cytokines are involved in IGF-1-induced activation of STAT3, we preincubated the murine cardiomyocytes with RX435 (anti-gp130 blocking antibody) and stimulated the cells with either LIF or IGF-1 ( Figure 6B ). Preincubation of RX435 strongly inhibited the phosphorylation of STAT3 by LIF, whereas it did not 
Takahashi et al IGF-1 Stimulates the JAK/STAT Pathway 887
inhibit that by IGF-1, suggesting that paracrine-secreted IL-6 family cytokines were not involved in this phosphorylation. Next, we investigated whether other signaling pathways were involved in the activation of STAT3 in IGF-1-mediated signaling. We preincubated the cells with PD98059 (MEK inhibitor), wortmannin (PI-3K inhibitor), BAPTA-AM, EDTA, KN62 (calmodulin kinase II inhibitor), or chelerythrine (protein kinase C [PKC] inhibitor) for 30 minutes and measured the IGF-1-induced tyrosine phosphorylation of STAT3 at 60 minutes. The tyrosine phosphorylation of STAT3 was not affected by PD98059, wortmannin, EDTA, or KN62 but was significantly attenuated by BAPTA-AM and chelerythrine ( Figure 7A ). Densitometric analysis confirmed that BAPTA-AM and chelerythrine inhibited the IGF-1-induced tyrosine phosphorylation of STAT3 by 95% and 98%, respectively ( Figure 7B ). These findings indicated that intracellular Ca 2ϩ and PKC were involved in IGF-1-induced delayed tyrosine phosphorylation of STAT3 in cardiomyocytes.
Upstream Signals of the Serine Phosphorylation of STAT1
Previous reports demonstrated that both raf-1/MEK/ERKdependent and -independent pathways were involved in serine phosphorylation of STATs. Upstream signals of the serine phosphorylation of STATs are now considered to be both ligand and cell type specific. Thus, we preincubated the cells with BAPTA-AM, EDTA, KN62, chelerythrine, PD98059, or wortmannin for 30 minutes and measured the IGF-1-induced tyrosine phosphorylation of STAT1 ( Figure  8 ). The serine phosphorylation of STAT1 was not affected by any of the inhibitors used. These results indicated that IGF-1-induced serine phosphorylation STAT1 was independent of the PKC, PI-3K, Ca 2ϩ /calmodulin/CaMKII, and raf-1/MEK/ERK pathways.
Discussion
There is increasing evidence for the involvement of the JAK/STAT pathway in insulin-mediated signaling, but the . IGF-1-induced tyrosine phosphorylation of STAT3 was independent of autocrine/paracrine-secreted angiotensin II, endothelin-1, and IL-6 family cytokines. A, Effect of paracrine factors on IGF-1-induced sustained tyrosine phosphorylation of STAT3 was examined. Cardiomyocytes were preincubated with ET-A, B-receptor antagonist (TAK044), and AT 1 antagonist (CV11974) for 30 minutes and then were stimulated with IGF-1. IGF-1-induced tyrosine phosphorylation of STAT3 was not affected by TAK044 or CV11974, indicating that paracrine-secreted endothelin-1 and angiotensin II were not involved in this activation. B, Murine cardiomyocytes were preincubated with RX435 (anti-gp130 blocking antibody) and were stimulated with either LIF (1000 U/mL, 5 minutes) or IGF-1 (10 Ϫ8 mol/L, 60 minutes), and tyrosine phosphorylation of STAT3 was measured. RX435 significantly inhibited LIF-induced tyrosine phosphorylation of STAT3, but it did not inhibit that of IGF-1.
detailed interactions within this pathway or with other signaling pathways remain unclear. Moreover, it has not yet been determined how this pathway is involved in IGF-1-mediated signaling, although the insulin and IGF-1 receptors are closely related. In the present study, we found that IGF-1 activated JAK1 but not JAK2 or Tyk2 in cardiomyocytes. IGF-1 induced both tyrosine and serine phosphorylation of STAT1 and STAT3. The time course of the tyrosine phosphorylation of STAT1 was in accordance with that of JAK1 but that of STAT3 was sustained and was dissociated from the activation of JAK1. In addition, the time course of the mobility shift of SIE coincided with the phosphorylation of STAT3. Finally, PKC and intracellular Ca 2ϩ were found to be required for the tyrosine phosphorylation of STAT3.
Giorgetti-Peraldi 25 reported that in fibroblasts overexpressing insulin receptor both JAK1 and JAK2 were constitutively associated with Grb2 through the SH3 domains of Grb2, and that insulin induced the tyrosine phosphorylation of JAK1 but did not modify the tyrosine phosphorylation state of JAK2. However, Saad et al 26 reported that insulin did induce tyrosine phosphorylation of JAK2 in insulin-sensitive tissues of the intact rat. Gual et al 27 reported that in fibroblasts overexpressing insulin and IGF-1 receptor, insulin and IGF-1 lead to phosphorylation and activation of JAK1 and JAK2, and that JAK1 phosphorylated IRS-1 on sites different from those phosphorylated by the insulin receptor and interacted directly with phosphorylated insulin and IGF-1 receptor. 27 We have observed that IGF-1 induced tyrosine phosphorylation of JAK1 but not JAK2 or Tyk2 in cardiomyocytes. Our findings for JAK1 in cardiomyocytes agree with the results obtained in fibroblasts overexpressing IGF-1 receptor 27 ; however, we did not observe the enhancement of tyrosine phosphorylation of JAK2 in cardiomyocytes. One reason for this difference was the different cell types used. The IGF-1-induced tyrosine phosphorylation of JAK2 was observed in cells that overexpressed IGF-1 receptor, and the maximal phosphorylation of JAK2 was only 1.9Ϯ0.2-fold of the control. Thus, we believe that JAK1, but not JAK2, is critically involved in IGF-1-mediated signaling in primary cultured cardiomyocytes.
STAT proteins regulate cell growth and differentiation. Chuang et al 28 reported that insulin rapidly tyrosine-phosphorylated STAT1␣ and increased its specific binding activity to a GAS/ISRE consensus oligonucleotide in HEP3B cells. They also reported that JAK1, JAK2, and Tyk2 were not tyrosine-phosphorylated at 15 minutes and concluded that this phosphorylation was caused by a JAK-independent pathway. We have observed IGF-1 tyrosine-phosphorylated suggests that JAK1 mediated IGF-1-induced tyrosine phosphorylation of STAT1␣ in cardiomyocytes. IGF-1-induced tyrosine phosphorylation of JAK1 peaked at 5 minutes, decreased at 15 minutes, and was apparently weaker than that induced by LIF. According to the data presented by Gual et al, 27 insulin-induced tyrosine phosphorylation of JAK1 peaked at 2 to 5 minutes and decreased at 10 minutes. Thus, Chuang et al 28 may have missed the peak of JAK1 phosphorylation.
In contrast to STAT1␣, we observed that IGF-1 induced the sustained tyrosine phosphorylation of STAT3 and mobility shift of SIE in cardiomyocytes. Coffer et al 29 reported that the SIF complex (STAT3 dimer) was rapidly induced by insulin and was sustained for several hours, and that ERK and PI-3K were not required for this activation. Our observation of the IGF-1-induced phosphorylation of STAT3 was in accordance with their observations with insulin. It is possible to explain the early phase of the activation of STAT3 by induction by JAK1, but it is difficult to explain the entire time course of this phosphorylation by JAK1 alone. The present study revealed that IGF-1-induced tyrosine phosphorylation of STAT3 was blocked by BAPTA-AM and chelerythrine but not by PD98059, wortmannin, EDTA, or KN62. These findings indicated that this long-lasting phosphorylation required certain levels of [Ca 2ϩ ] i and PKC but did not require the MEK/ERK pathway, PI-3K, or Ca 2ϩ /calmodulin kinase II. Recent evidence indicated that the transforming tyrosine kinases encoded by v-Src, v-Abl, Bmx, and v-Fps can induce STAT activation, 30 -32 suggesting that their normal cellular homologs such as c-Src and c-Fes may contribute to STAT activation under physiological conditions. 33 Moreover, a recent report revealed that insulin receptor-␤ directly phosphorylates STAT5, suggesting that STAT3 might be another substrate for insulin and the IGF-1 receptor. 34, 35 Although we could not determine which tyrosine kinase was involved in this phosphorylation, a Ca 2ϩ -dependent PKC might exist upstream of the kinase.
Recent studies have revealed that maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. 24 Zhu et al 36 reported that interferon-␥ induced both serine and tyrosine phosphorylation of STAT1, and that STAT1 serine phosphorylation is more delayed than tyrosine phosphorylation. They also reported that the ras/MAPK pathway was not involved in interferon-␥-induced STAT1 serine phosphorylation. 36 The present study revealed that the time course of the serine/ tyrosine phosphorylation of STAT1 by IGF-1 was similar to that by interferon-␥. We have also shown that the upstream signal of serine phosphorylation of STAT1 was independent of PKC, PI3-K, Ca 2ϩ /calmodulin/CaMKII, or raf-1/MEK/ ERK pathways. These findings were also similar to those for interferon-␥.
Chung et al 37 reported that serine phosphorylation of STAT3 was mediated by both ERK-dependent and -independent pathways. Ceresa et al 38, 39 reported that insulin induced STAT3 serine phosphorylation by a Ras/Raf-1/ MEK-dependent pathway. In the present study, we attempted to determine the upstream pathway of serine phosphorylation of STAT3 by IGF-1. The Raf-1/MEK/ERK pathway was partially involved in the serine phosphorylation of STAT3 (data not shown). However, we could not definitively determine the upstream pathway of the serine phosphorylation of STAT3. This is probably because the serine phosphorylation of STAT3 was sustained, and several pathways might be involved in this activation. The pathway upstream of the IGF-1-induced serine phosphorylation of STAT1 and STAT3 needs to be clarified in the future.
The mechanism of activation of the IGF-1-induced JAK/ STAT pathway is both very complicated and quite different 
Materials
Materials and Methods
Recombinant
purchased from Pharmacia Biotech.
Cell culture
Primary cultures of cardiomyocytes were prepared from ventricles of l-day-old Wistar rats as described previously".
5'-5'-
was the The cardiomyocytes were collected by differential adhesiveness. Cells were seeded at a density of lx105cells/cm2 on gelatin-coateddishes.
Twelve hours after plating, bromodeoxyuridine was added to medium at a concentration of 10-l mol/L for 12 hours to arrest the proliferative response of nonmyocytes. The cells were washed with the same medium, and were incubated for 24 hours at which time the cardiomyocytes had formed syncytium and were beating synchronously.
They were incubated in serum-free medium for 24 hours, and then stimulated with IGF-1 (lo-' mol/L). The nonmyocyte population was approximately 5-10% as evaluatedby immunofluorescence stainingwith anti-sarcomeric myosin antibody (MF20).
IP-Western Blot Analysis
The cells were washed with Dulbecco's PBS, and were lysed in a buffer containing 20 mM Tris-HCl (pH 7.4 ) , 100 mM NaCl, 5 mM EDTA,
1.0% Triton X-100, 10% glycerol, 0.1% SDS, 1.0% deoxycholic acid, 50 mMNaF, 10 mMNa3Pz07, lmMNa3V04, 1 mMphenylmethylsulfony1 fluoride (PMSF), 10 pg/ml aprotinin and 10 pg/ml leupeptin. The lysates were precleared by incubation with protein A-sepharose beads (Sigma).
Precipitating antibodies were added to the lysates, and the lysates were incubated for 3 hours at 4°C. Immunoprecipitates were pelleted with protein-A sepharose beads, and washed 4 times with the lysis buffer. The precipitated proteins were subjected to SDS-PAGE, and
Western blot analysis was performed as described previously". The membranes were incubated with appropriate antibodies for 2 hours at 23"C, and incubated with peroxydase-conjugated goat anti-mouse or rabbit IgG. Signals were visualized with an ECL (Amersham).
Kinase activity assays for Raf-1. supplemented with protease and phosphatase inhibitors. The nuclear extracts were dialyzed against dialysis buffer (same composition as the high-salt buffer except that KC1 content was 100 mmol/L and glycerol content was 20%) overnight. The protein content was determined by Bradford assay.
Gel mobility shift assay
Cardiomyocytes were rinsed with PBS at O"C, and scraped into buffer. The protein concentrations were determined by Bradford's method, and the extracts were stored at -80°C. Nuclear extracts (5
